Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Oracle Corporation (ORCL) Closes a Door and Opens a Window on Cloud

Page 1 of 2

Oracle CorporationOracle Corporation (NASDAQ:ORCL) made two big deals this week.

First, and most important, it agreed to let its database software and Java language run on Microsoft Corporation (NASDAQ:MSFT) Azure cloud. It had already been running on Windows server.

Second, it made peace with rival, inc. (NYSE:CRM), with the Software as a Service vendor agreeing to buy both Oracle hardware and software going forward.

What does this mean for all three companies?

Microsoft gets cloud relevance

Microsoft Corporation (NASDAQ:MSFT) is the big winner in this.

The company has been lagging in the cloud wars for some time, because its Azure is not an infrastructure, but a platform, with all the tools needed for companies to move applications to the cloud.

What makes this a problem? Cost, and the vendor lock-in inherent in becoming dependent on one company’s tools for your technology future.

Even after the company announced it would sell “bare-bones” infrastructure and set its prices to match those of Amazon.Com, which is leading in the public cloud race, Microsoft seemed unable to gain traction.

The Oracle Corporation (NASDAQ:ORCL) deal changes this. Oracle has a ton of enterprise customers who want workloads moved to cloud eventually, and this gives them a way to do so in a way that’s price-competitive with what Amazon offers.

This will create a short-term hit to earnings – Amazon isn’t making money on cloud so chances are Microsoft Corporation (NASDAQ:MSFT) won’t either – but it will make for top-line growth, and provide huge opportunities for cross-selling to companies that had standardized on Windows years ago.

This doesn’t solve Microsoft’s bigger problem – the rise of Bring Your Own Device (BYOD) programs at large companies which heavily favor Google Android and Apple’s iOS – but it’s a big win nonetheless.

Oracle gets into cloud

For Oracle Corporation (NASDAQ:ORCL) the Microsoft Corporation (NASDAQ:MSFT) deal was a necessity, and the, inc. (NYSE:CRM) deal is a pure win.

For the last year Oracle has been selling something called “Oracle Cloud” which is, as David Linthicum of Gigaom has said repeatedly, actually “faux cloud.” When your “cloud” is based entirely on proprietary hardware and software, when it requires expensive purchases of big iron servers like those Oracle Corporation (NASDAQ:ORCL) brands as Exadata, it doesn’t matter that the result lets you do virtualization and share work loads among many devices. You’re not getting the savings cloud promises.

Now, Oracle can keep those customers and give them a cost-effective solution for real cloud workloads. It will probably lose some Exadata sales over this, but those were sales it was going to lose anyway, because companies concerned about “faux cloud” were looking to ditch Oracle Corporation (NASDAQ:ORCL) entirely. This prevents that.

As to, inc. (NYSE:CRM), this is a big win for Oracle. It means money coming into the Exadata unit. It means peace in our time with a leading vendor or Oracle solutions. And the word will now go out, plainly, that these are in fact Oracle Corporation (NASDAQ:ORCL) solutions, which should help the company’s sales staff going forward.

What did do?

On the surface this doesn’t make sense for, inc. (NYSE:CRM). In the long run, maybe it doesn’t.

But in the short-term, over the next year or two, this is an important deal, and it provides CEO Marc Benioff with an eventual escape hatch.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!